Cyr61 inhibitors target and modulate the activity of the Cyr61 protein. Cyr61, also known as CCN1, belongs to the CCN (Cyr61/CTGF/Nov) family of matricellular proteins, which are secreted into the extracellular matrix and play multifaceted roles in cellular functions and tissue remodeling. Cyr61 is involved in diverse cellular processes, and its functions are mediated through interactions with various cell surface receptors, such as integrins and heparan sulfate proteoglycans. Upon binding to these receptors, Cyr61 triggers intracellular signaling pathways that modulate cellular responses to extracellular cues. It is an essential regulator of processes like cell adhesion, migration, proliferation, and survival. Additionally, Cyr61 plays a pivotal role in angiogenesis, the formation of new blood vessels from pre-existing ones, which is crucial for tissue growth and repair. Cyr61 inhibitors are specifically designed to disrupt the interactions between Cyr61 and its cellular receptors, disrupting the transmission of intracellular signals that would typically be initiated by Cyr61 binding. By doing so, these inhibitors can interfere with downstream gene expression and cellular responses that are influenced by Cyr61's activities.
The chemical structures of Cyr61 inhibitors may vary significantly, as researchers continually refine and optimize these compounds to enhance their selectivity and efficacy in modulating Cyr61's functions. The exact mechanisms by which Cyr61 inhibitors interact with Cyr61 and inhibit its activity can also differ based on their specific molecular properties. The targeted modulation of Cyr61 activity by these inhibitors has proven to be an invaluable tool in basic research. By using Cyr61 inhibitors, scientists can delve into the intricate regulatory networks that govern various cellular processes, shedding light on the significance of Cyr61 in normal physiological functions. Cyr61 inhibitors represent a specialized chemical class of compounds designed to selectively target Cyr61 and disrupt its interactions with cellular receptors. Through this targeted modulation, these inhibitors offer valuable tools for researchers to investigate the multifaceted roles of Cyr61 in cellular processes, tissue homeostasis, and angiogenesis, contributing to the advancement of knowledge in various fields of cellular biology.
Siehe auch...
| Produkt | CAS # | Katalog # | Menge | Preis | Referenzen | Bewertung |
|---|---|---|---|---|---|---|
NSC 632839 hydrochloride | 157654-67-6 | sc-204138 sc-204138A | 10 mg 50 mg | $119.00 $465.00 | ||
Hemmt die Expression von COL2A1 und die Synthese von Kollagen Typ II und reduziert so den Knorpelabbau und den Umbau der extrazellulären Matrix bei Gelenkerkrankungen wie Arthrose. | ||||||
SB-3CT | 292605-14-2 | sc-205847 sc-205847A | 1 mg 5 mg | $100.00 $380.00 | 15 | |
Hemmt die Transkription des COL2A1-Gens und die Aktivierung von MMP-2/9, wodurch der Knorpelabbau und die mit Arthrose verbundenen Entzündungsprozesse verringert werden. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $155.00 | 6 | |
Verringert die COL2A1-Expression und die pro-inflammatorischen Zytokine und mildert so die Knorpelzerstörung bei Arthritis durch seine entzündungshemmenden Eigenschaften. | ||||||
Chondroitinase ABC from Proteus vulgaris | 9024-13-9 | sc-507341 | 2 U | $650.00 | ||
Spaltet Glykosaminoglykan-Ketten auf Aggrecan, moduliert den COL2A1-Umsatz und den Matrixumbau bei Knorpelreparaturprozessen. | ||||||
Heat Shock Protein Inhibitor I | 218924-25-5 | sc-221709 | 5 mg | $95.00 | 5 | |
Hemmt indirekt Hsp70, wodurch die Expression von COL2A1 verringert wird und möglicherweise therapeutische Vorteile bei Arthritis und anderen kollagenbedingten Erkrankungen erzielt werden können. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Blockiert Rho-assoziierte Proteinkinasen (ROCK), wodurch die COL2A1-Synthese reguliert und Fibrose- und Knorpelerkrankungen gelindert werden könnten. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
Es hemmt die Ca2+/Calmodulin-abhängige Proteinkinase II (CaMKII), wodurch die COL2A1-Expression und die kalziumabhängigen kollagenbezogenen Signalwege abgeschwächt werden. | ||||||
Piperine | 94-62-2 | sc-205809 sc-205809A | 5 g 25 g | $36.00 $143.00 | 3 | |
Reduziert COL2A1 und die entzündlichen Zytokine, wodurch der Knorpelabbau bei Arthritis durch seine entzündungshemmenden Eigenschaften gelindert werden könnte. | ||||||